Douglas E Richards - Net Worth and Insider Trading
Douglas E Richards Net Worth
The estimated net worth of Douglas E Richards is at least $627,900 dollars as of 2024-11-13. Douglas E Richards is the VP of Business Development of ACADIA Pharmaceuticals Inc and owns about 35,000 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $627,900. Details can be seen in Douglas E Richards's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas E Richards has not made any transactions after 2004-05-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas E Richards
Douglas E Richards Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas E Richards owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Douglas E Richards’s form 4 insider trades.
Insider Ownership Summary of Douglas E Richards
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2004-05-26 | VP of Business Development |
Douglas E Richards Latest Holdings Summary
Douglas E Richards currently owns a total of 1 stock. Douglas E Richards owns 35,000 shares of ACADIA Pharmaceuticals Inc (ACAD) as of May 26, 2004, with a value of $627,900.
Latest Holdings of Douglas E Richards
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2004-05-26 | 35,000 | 17.94 | 627,900 |
Holding Weightings of Douglas E Richards
Douglas E Richards Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas E Richards has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 0 shares on May 26, 2004, which brought Douglas E Richards around $0.
Insider Trading History of Douglas E Richards
- 1
Douglas E Richards Trading Performance
Douglas E Richards Ownership Network
Ownership Network List of Douglas E Richards
Ownership Network Relation of Douglas E Richards
Douglas E Richards Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Douglas E Richards is the VP of Business Development of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Douglas E Richards made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .
In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
Douglas E Richards Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas E Richards. You might contact Douglas E Richards via mailing address: 3911 Sorrento Valley Boulevard, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
